Search by Drug Name or NDC

    NDC 61314-0245-01 Betaxolol Hydrochloride 5.6 mg/mL Details

    Betaxolol Hydrochloride 5.6 mg/mL

    Betaxolol Hydrochloride is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is BETAXOLOL HYDROCHLORIDE.

    Product Information

    NDC 61314-0245
    Product ID 61314-245_c30e555b-1a79-4c3e-b79d-8c1d950fd832
    Associated GPIs 86250010102005
    GCN Sequence Number 007857
    GCN Sequence Number Description betaxolol HCl DROPS 0.5 % OPHTHALMIC
    HIC3 Q6G
    HIC3 Description MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS
    GCN 33210
    HICL Sequence Number 005168
    HICL Sequence Number Description BETAXOLOL HCL
    Brand/Generic Generic
    Proprietary Name Betaxolol Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Betaxolol Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 5.6
    Active Ingredient Units mg/mL
    Substance Name BETAXOLOL HYDROCHLORIDE
    Labeler Name Sandoz Inc
    Pharmaceutical Class Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA019270
    Listing Certified Through 2024-12-31

    Package

    NDC 61314-0245-01 (61314024501)

    NDC Package Code 61314-245-01
    Billing NDC 61314024501
    Package 1 BOTTLE, PLASTIC in 1 CARTON (61314-245-01) / 5 mL in 1 BOTTLE, PLASTIC
    Marketing Start Date 2000-05-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 8.314
    Pricing Unit ML
    Effective Date 2023-12-20
    NDC Description BETAXOLOL HCL 0.5% EYE DROP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5, 6
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis